Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/08/2003US20030086945 Porcine reproductive and respiratory syndrome virus and methods of use
05/08/2003US20030086901 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003US20030086881 Antiinfective combinations and their use for the topical treatment of fungal infections of the toenails and fingernails
05/08/2003US20030086880 Antimicrobial artificial nail composition and methods for preparing and using same
05/08/2003CA2465405A1 Controlled release compositions for macrolide antimicrobial agents
05/08/2003CA2465402A1 Anthrax antigenic compositions
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465305A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464303A1 Method for treating retroviral infections
05/08/2003CA2464031A1 Purine analogs having hsp90-inhibiting activity
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462652A1 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1308462A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
05/07/2003EP1308448A1 Method for the preparation of chromanone
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308160A1 Highly absorbable solid preparation
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307746A1 Identification of viral agents in breast ducts and antiviral therapy therefore
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307565A2 Vaccination against host cell-associated herpesviruses
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307540A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
05/07/2003EP1307539A2 Gene expression profile for kshv infection and methods for treating same
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307468A1 Macrolide antibiotics
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307445A1 Benzofuran derivatives and their use as antibacterial agents
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307227A2 Pharmaceutical compositions
05/07/2003EP1307222A2 Non-human animal models of tolerance to hepatitis c virus immunogens
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307213A2 Chlorella preparations exhibiting immunomodulating properties
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307198A1 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307104A1 A new antibacterial composition comprising as an active ingredient saponificated vegetable oil
05/07/2003EP1272512A4 Immunokine composition and method
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1054681B1 The use of combinations of active agents consisting of antibiotics and plant extracts containing terpene in veterinary medicine
05/07/2003EP1027361B1 6,11-bridged erythromycin derivatives
05/07/2003EP0993462B1 Calixarene tubes as cation receptors
05/07/2003EP0987267B1 Carbapenem compounds, use thereof, and intermediate compounds of the same
05/07/2003EP0981527B1 Salt of naphthyridine carboxylic acid derivative
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0853633B1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0836648B1 Recombinant mva virus, and the use thereof
05/07/2003EP0821687B1 Preparation of clavulanate salts
05/07/2003EP0762889B1 Heparin-binding protein for the treatment of sepsis
05/07/2003EP0741570B1 Preventing or reducing photosensitivity and/or phototoxicity reactions to antiinfective medications
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses
05/07/2003CN1416431A Nucleoside compounds and uses thereof
05/07/2003CN1416430A 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
05/07/2003CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416353A Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails
05/07/2003CN1416352A Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
05/07/2003CN1416351A HIV immune adjuvant therapy
05/07/2003CN1416347A Agent for treating hepatitis C
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415615A New compound of natrium cefdinir
05/07/2003CN1415372A Medicament compsn. for curing acute pharyngitis and its preparation method
05/07/2003CN1415371A Medicament for curing colpitis mycotica and trichomonal vaginitis and its preparation method
05/07/2003CN1415365A Chinese medical preparation for preventing and curing blaze of shrimps corpus hemorrhagicum, gill rot and pond syndrome
1 ... 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 ... 1798